Vascular Closure Devices

This channel includes news and new technology innovations for vascular closure devices used to rapidly seal and achive hemostatsis at vascular access sites in interventional cardiology procedures. 

Leveraging Vivasure Medical’s PerQseal vascular closure device technology, PerQseal Blue consists of an intravascular patch designed to seal the vessel from the inside, returning the vein to its natural state after it dissolves over time, so no foreign bodies are left behind.

Leveraging Vivasure Medical’s PerQseal vascular closure device technology, PerQseal Blue consists of an intravascular patch designed to seal the vessel from the inside, returning the vein to its natural state after it dissolves over time, so no foreign bodies are left behind.
 

News | Vascular Closure Devices | July 15, 2021
Vivasure Medical is Developing a Sutureless Venous Closure Device for Transcatheter Valve Procedures
July 15, 2021 — Vivasure Medical announced its development program for PerQseal Blue, a sutureless and fully...
read more
Videos | Radial Access | May 06, 2021
VIDEO: Radial Hemostasis Reduced by 50 Percent With StatSeal in Combination With TR Band
Arnold Seto, M.D., MPA, FSCAI, chief of cardiology, Long Beach Veterans Affairs Medical Center and director,...
read more
The STAT2 trial used a combination of the Biolife Statseal potassium ferrate hemostatic patch and a Terumo TR Band to reduce radial access arteriotomy site hemostasis by 50 percent.

The STAT2 trial used a combination of the Biolife Statseal potassium ferrate hemostatic patch and a Terumo TR Band to reduce radial access arteriotomy site hemostasis by 50 percent.

News | Radial Access | April 28, 2021 | Dave Fornell, Editor
Radial Hemostasis Time Cut by 50 Percent With StatSeal in Combination With TR Band
April 28, 2021 — A new study reveals the use of a potassium ferrate hemostatic patch (PFHP) reduces the time to...
read more
The FDA’s market clearance occurred once the agency reviewed EnsiteVascular’s Section 510(k) premarket notification of intent to market the SiteSeal SV device and determined it is substantially equivalent for the indication for use stated: brachial artery closure. Previously, EnsiteVascular received FDA market clearance for SiteSeal SV for radial artery closure.
News | Hemostasis Management | April 21, 2021
FDA Clears SiteSeal SV Vascular Closure Device for the Brachial Arteries
April 21, 2021 — EnsiteVascular announced it received its second U.S. Food and Drug Administration (FDA) market...
read more
Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.
News | Vascular Closure Devices | August 17, 2020
Vasorum Partners With Veryan to Commercialize of New Vascular Closure Device in U.S.
August 17, 2020 — Veryan Medical announced it will support Vasorum in the commercialization of the Celt atrial closure...
read more
News | Radial Access | December 30, 2019
Merit Medical Announces its EVOlution in Radial Hemostasis in Europe
December 30, 2019 — Merit Medical Systems Inc., a leading manufacturer of proprietary devices used primarily in...
read more
The Saranas Early Bird Bleed Monitoring System offers real-time detection and monitoring of transcatheter intervention vascular access site bleed complications.

The Saranas Early Bird Bleed Monitoring System offers real-time detection and monitoring of transcatheter intervention vascular access site bleed complications.

News | Vascular Access | November 07, 2019
Early Bird Bleed Monitoring System Used in First Commercial U.S. Patient
November 6, 2019 — Saranas Inc. announced completion of the first U.S. commercial case using its Early Bird Bleed...
read more
Videos | Vascular Closure Devices | October 17, 2019
VIDEO: Use of Large Bore Vascular Closure
Ashish Pershad, M.D., chief of interventional cardiology, Banner University Medical Center, Phoenix, explains the trend...
read more
Cordis Announces U.S. Launch of Radial 360 Portfolio
Technology | Radial Access | May 15, 2019
Cordis Announces U.S. Launch of Radial 360 Portfolio
May 15, 2019 — Cordis, a Cardinal Health company, recently announced the full U.S. launch of its Radial 360 portfolio,...
read more
Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.
Technology | Vascular Closure Devices | April 03, 2019
Large-Bore Vascular Closure Device Cleared by the FDA
April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore...
read more
FDA Approves Vascade MVP Vascular Closure System
Technology | Vascular Closure Devices | December 20, 2018
FDA Approves Vascade MVP Vascular Closure System
December 20, 2018 — Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food...
read more
PerQseal Large Bore Closure Device Launches in Europe
News | Vascular Closure Devices | November 21, 2018
PerQseal Large Bore Closure Device Launches in Europe
November 21, 2018 – Vivasure Medical Ltd. recently announced the European launch of the PerQseal closure device for...
read more
Vascade MVP Reduces Time to Ambulation Follow EP Procedures
News | Vascular Closure Devices | November 11, 2018
Ambulation Time Following EP Procedures Decreased With Vascular Closure Device
November 12, 2018 — The Vascade MVP vascular closure system met its endpoints compared to manual compression in a...
read more
Technology | Vascular Closure Devices | November 05, 2018
Cordis Launches Mynx Control Vascular Closure Device
November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure...
read more
Teleflex Acquires Essential Medical
News | Vascular Closure Devices | October 05, 2018
Teleflex Acquires Essential Medical
October 5, 2018 — Teleflex Inc. announced the acquisition of Essential Medical Inc. Based in Exton, Pa., Essential...
read more
© Copyright Wainscot Media. All Rights Reserved.